Dr. Mikhail Y. Berezin's lab at Washington University focuses on understanding how the brain adapts after traumatic peripheral nerve injuries. They use advanced imaging techniques to visualize both nerve regeneration and brain responses in real time, which helps to reveal the relationship between nerve healing and brain plasticity. By studying these interactions, the lab aims to develop better therapies for patients suffering from nerve injuries.

Dr. Hanwen Zhang's lab at Washington University focuses on improving treatments for neuroblastoma, a challenging pediatric cancer. The research involves developing advanced therapies that combine novel radiopharmaceuticals to better target cancer cells while minimizing harm to surrounding tissues. By exploring high linear energy transfer (LET) agents, the lab aims to enhance treatment efficacy and optimize patient care for children suffering from relapsed neuroblastoma.

The lab led by Qing Wang at Washington University focuses on developing innovative imaging techniques to study neuroinflammation associated with Alzheimer's disease. They are working on a new method called diffusion dictionary imaging (DDI), which uses MRI technology to visualize and quantify neuroinflammation in the brain. This research aims to better understand the relationship between neuroinflammation and the progression of Alzheimer's disease.

Dr. Evan M. Gordon's lab at Washington University focuses on understanding Parkinson's Disease (PD) by studying a newly identified brain circuit known as the Somato-Cognitive Action Network (SCAN). This research aims to determine how SCAN is connected to critical subcortical structures involved in PD, which may lead to new treatment targets for the disease. By employing advanced noninvasive imaging techniques, the lab seeks to redefine our understanding of PD, potentially improving patient evaluation and treatment through pinpointing specific brain regions affected by the disorder.

Dr. Meghan C. Campbell's lab at Washington University focuses on understanding Parkinson's disease through advanced brain imaging techniques. The lab aims to identify individual differences in brain network organization that can serve as biomarkers for the disease. By linking these biomarkers to cognitive and psychiatric symptoms, the research seeks to pave the way for personalized treatments that address the complex manifestations of Parkinson's disease.

Dr. Ismael Seanez's lab at Washington University focuses on developing non-invasive treatments for spinal cord injuries (SCI) using transcutaneous spinal cord stimulation (tSCS). The research aims to restore motor functions like walking and hand use through controlled muscle activation without invasive methods. By better understanding how different stimulation parameters affect muscle recruitment, the lab hopes to personalize rehabilitation therapies for individuals with SCI.

Dr. Abhinav K Jha's lab focuses on enhancing cancer treatment through advanced imaging techniques. Specifically, they are developing a new method for quantitative imaging of alpha-particle therapies, which are promising treatments for metastatic cancers like prostate cancer. The research aims to accurately measure how much of these therapies are absorbed in both cancerous and healthy tissues, ultimately improving treatment personalization and effectiveness for patients.

Dr. Patricia Ribeiro Pereira's lab focuses on improving cancer treatments, specifically for breast and gastric cancers. They are exploring innovative antibody-drug conjugates that enhance drug delivery to tumor cells, especially in cases where tumors have developed resistance to standard therapies. By using special antibody pairs that can bind more effectively to cancer cells, the lab aims to make existing treatments more effective and potentially prevent drug resistance in the future.

Dr. Jie Zheng's lab focuses on advancing cardiac imaging techniques, particularly using magnetic resonance imaging (MRI) to assess how much oxygen the heart muscles extract from the blood. They develop innovative methods that are non-invasive and do not expose patients to harmful radiation, making them safer and potentially more available than existing techniques like PET scans. The lab's research not only aims to improve diagnostic capabilities for heart diseases but also to provide insights into treatment responses for various cardiac conditions.

Dr. Sana D Karam's lab at Washington University focuses on understanding how estrogen influences cancer treatment, particularly in head and neck cancer (HNSCC), which affects more men than women. The lab investigates the roles of specific immune cells and hormonal signaling in response to therapies, aiming to enhance treatment outcomes for women, especially those who are premenopausal. Research explores how estrogen can alter immune responses and tumor environments to better tailor cancer therapies based on sex and hormonal status.

Dr. Kooresh Isaac Shoghi's lab focuses on improving treatment options for patients with advanced breast cancer by studying how certain therapies work with estrogen receptors. Specifically, they investigate the use of PET imaging to predict which patients might benefit from hormone therapies instead of more aggressive treatments like chemotherapy. This research aims to make cancer treatment more personalized and effective for patients with hormone-sensitive breast cancer.

Nathaniel Huebsch's laboratory at Washington University focuses on combining advanced computational methods and smart materials to create innovative systems that simulate how mechanical forces affect tissues. By integrating real-time monitoring and control of tissue environments, the lab aims to improve drug screening processes and enhance the understanding of mechanobiology. This work has the potential to significantly impact how drug effects are studied, making them more applicable to real-life clinical scenarios.

Dr. Muriah D. Wheelock's research lab focuses on understanding how early brain development impacts neurological health later in life, particularly in relation to Alzheimer's disease and other neurodegenerative disorders. The lab studies brain functional connectivity in infants and toddlers to explore how early life experiences and conditions, such as low birth weight or trauma, influence brain development and long-term health outcomes. By analyzing brain imaging data and employing advanced techniques, the lab aims to uncover critical patterns that can inform prevention and intervention strategies for childhood development and aging.

Dr. Zhude Tu's research lab focuses on understanding neuroinflammation in neurodegenerative diseases such as Parkinson's disease and multiple sclerosis. Using advanced imaging techniques like positron emission tomography (PET), the lab aims to develop new radiotracers to visualize critical receptors involved in inflammation. This work not only seeks to identify biomarkers for these conditions but also explores potential therapeutic targets to improve treatment outcomes.

Dr. Andrei G. Vlassenko's research focuses on understanding brain metabolism, especially as it relates to aging and Alzheimer's disease. His lab uses advanced imaging techniques, like PET and MRI, to explore how the brain uses oxygen and glucose during mental tasks, and how this might change in older adults and those with cognitive impairments. The goal is to uncover the metabolic processes involved in brain health and disease, which could lead to new insights on preventing cognitive decline.

Dr. Christine O'Brien's lab works on developing innovative wearable devices that can help monitor blood loss during childbirth, specifically aiming to address postpartum hemorrhage (PPH). By creating technologies that non-invasively measure important cardiovascular parameters, the lab seeks to provide early detection of PPH, which is crucial for improving patient outcomes and reducing maternal mortality. The research combines biomedical engineering and real-world clinical applications to enhance maternal health.

Dr. Pamela K Woodard's lab focuses on understanding carotid artery diseases, specifically atherosclerosis, which can lead to strokes. Using advanced PET imaging techniques, the research aims to differentiate between patients at high risk of plaque rupture and those who may not need surgical intervention. By studying specific molecular markers in patients, the lab hopes to improve treatment strategies and reduce unnecessary healthcare costs.

Dr. Dmitriy A. Yablonskiy's research lab focuses on developing advanced MRI techniques to improve the early detection of Alzheimer's Disease and its progression. The lab is working on a novel MRI method called Deep-Learning-Augmented quantitative Gradient Recalled Echo (DLA-qGRE), which allows for better identification of brain microstructural changes associated with neurodegeneration before significant symptoms appear. This work aims to create efficient, non-invasive diagnostic tools that can help monitor Alzheimer's and other neurodegenerative conditions.